Here’s whether Sabra Healthcare REIT, Inc. (SBRA) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.59% over 10 days); strong 1-year return of +10.1%. Concerns: RSI 26 — oversold. Currently 10.8% off its 52-week high. Score: +4/7.
SBRA is in a confirmed uptrend, trading above both its 50-day ($19.96) and 200-day ($19.68) moving averages. An RSI of 25.9 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +10.1% compares to +20.4% for SPY (trailed the market by 10.2%).
$10,000 invested 1 year ago→ $11,014 today
vs. S&P 500 (SPY) — same period trailed market by 10.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($19.68)
✓Above 50-day MA ($19.96)
!RSI(14) neutral zone (30–70) — currently 25.9
✓Positive return (+10.1%)
!Within 10% of period high (−10.8%)
Period Range $20.32
$17.17$22.77
RSI (14) 25.9
0 · OversoldOverbought · 100
Key Metrics
Price$20.32
Period Return+10.1%
Period High$22.77
Period Low$17.17
Drawdown−10.8%
MA-50$19.96
MA-200$19.68
RSI (14)25.9
Avg Volume (30d)3.0M
vs. SPYtrailed by 10.2%
Return Rank#577 of 1252
Trend Signals
Price is above the 200-day moving average ($19.68)